retatrutide resukts 🚨 JUST RELEASED TODAY!!!! NEW PHASE 3 DATA Today, July 23, 2026, new Phase 3 retatrutide results were released, adding to what is already one of the most interesting obesity drug retatrutide before and after Triathlon

As you build your healthcare network, opt for providers who tailor care to your stage of life, health goals, and individual needs

Glycemic Efficacy A meta-analysis of 66 randomized trials found that SGLT2 inhibitors decreased A1c levels by 0.4 to 1.1% (141)

These medications carry a boxed warning for medullary thyroid carcinoma and are contraindicated in patients with personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2

Heres how we approach GLP-1related shedding: Detailed History and Scalp Evaluation We start by understanding the full picture: Which GLP-1 youre on, when you started, and how your dose has changed How much weight youve lost and over what time frame Your current eating patterns, protein intake, and supplements Other medical conditions, medications, or recent stressors Family history of hair loss We then perform a targeted scalp exam

Health history: which conditions may affect suitability

Thinking About Starting a GLP-1 Medication